Skip to Main Content

Editor’s note: A recording of the conversation is embedded below.

Every week, STAT+ subscribers get access to exclusive conversations with biotech, pharma, and health tech leaders. This week, STAT general assignment reporter and associate editorial director of events Nicholas St. Fleur sits down with Fabrice Chouraqui, CEO of Cellarity and CEO-partner of Flagship Pioneering. They will be discussing how the new Flagship firm Cellarity recently raised $123 million to invent drugs by understanding cellular networks, what its next steps are, and of course be taking your questions live.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment